Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCHU de Quebec-Universite Laval
About this trial
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.
Eligibility criteria
Qualifiers
(specific to each study)
Disqualifiers
pregnant women <18 years old at recruitment
negative fetal heart at recruitment
women not able to provide an informed consent to the study
Trial design
Treatments tested in this trial
- Observational
Treatment groups
7,845 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov